1 Introduction Cancer-associated cachexia (CAC) is a progressive systemic metabolic disorder [1], accounts for 30% of all cancer-related deaths and affects up to 80% of advanced non-small-cell lung cancer patients [2, 3]. Skeletal muscle loss, which leads to functional impairment, is one of the most typical features of CAC. In clinical treatment, sufficient nutritional support and current clinical strategies fail to reverse muscle loss in these patients [4-6].
Yuqi Han
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yuqi
Contact Yuqi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack